Search - tctmd.com

Displaying 181 - 200 of 230

Sort: Relevancy | Date

News Daily News

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Yael L. Maxwell

November 06, 2014

News Daily News

El Cierre del AAI con Amplatzer parece Seguro y Eficaz en Pacientes con FA

Yael L. Maxwell

November 06, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

Presentation TCT 2014

Left Atrial Appendage Occlusion: Which Patient and Which Device?

Presenter: Philippe Généreux, Nicolo Piazza, Samer Mansour, Jean-Michel Paradis, David A. Wood

September 13, 2014

Presentation TCT 2014

Clinical Data and Rationale for Left Atrial Appendage Closure

Presenter: Gabriel Maluenda

September 13, 2014

News Daily News

研究发现，应当仅对风险最高的患者使用勒除器进行LAA封堵

Yael L. Maxwell

August 07, 2014

News Daily News

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Yael L. Maxwell

August 07, 2014

News Daily News

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

Yael L. Maxwell

August 07, 2014

Presentation LAA 2014

LARIAT: Clinical Trial Results & Future Trials

Presenter: Steven J. Yakubov

July 19, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

July 03, 2014

News Conference News EuroPCR 2014

Benefit of LAA Closure Becomes Most Evident After 1 Year

Caitlin E. Cox

May 23, 2014

Presentation EuroPCR 2014

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Presenter: Jos? Ram?n L?pez-M?nguez

May 21, 2014

Presentation TCT 2013

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Presenter: Ted Feldman

October 30, 2013

Presentation TCT 2013

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

Presenter: Paul Grayburn

October 30, 2013

Presentation TCT 2013

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Presenter: Brian Whisenant

October 30, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

News Daily News

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Yael L. Maxwell

June 07, 2013

Advertisement

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

El Cierre del AAI con Amplatzer parece Seguro y Eficaz en Pacientes con FA

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Left Atrial Appendage Occlusion: Which Patient and Which Device?

Clinical Data and Rationale for Left Atrial Appendage Closure

研究发现，应当仅对风险最高的患者使用勒除器进行LAA封堵

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

LARIAT: Clinical Trial Results & Future Trials

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

Benefit of LAA Closure Becomes Most Evident After 1 Year

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content